Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant

FMS-like tyrosine kinase 3 (FLT3) mutations are one of the most frequently encountered genetic alterations in acute myeloid leukemia (AML), and are generally associated with unfavorable outcomes. Several tools are currently available to provide an accurate prognosis for patients with these mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Mohty, Mohamad, Bazarbachi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826920/
https://www.ncbi.nlm.nih.gov/pubmed/31700594
http://dx.doi.org/10.1177/2040620719882666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826920/
https://www.ncbi.nlm.nih.gov/pubmed/31700594
http://dx.doi.org/10.1177/2040620719882666

Ejemplares similares